• Innovative
  • Scientific
  • Overview


It’s not unusual for someone to take several different medications at the same time. Yet pharmaceutical companies seldom study the effects of taking drugs in combination. Russ Altman, a Stanford professor of bioengineering, genetics and medicine, is pioneering the use of data mining to identify adverse as well as beneficial interactions. getAbstract believes his noteworthy discovery will interest members of the medical and technology communities.


Say your doctor prescribes two medications: a pill to address your high cholesterol and an antidepressant to tackle your depression. You can rest assured that the US Food and Drug Administration (FDA) has rigorously tested and approved each drug – in isolation. However, pharmaceutical firms rarely perform interaction studies among two or more drugs. Instead, they rely on “postmarketing surveillance.”

The FDA provides public access to an extensive database of “adverse event reports” from patients, physicians...

About the Speaker

Russ Altman is a professor of bioengineering, genetics and medicine at Stanford University.

More on this topic

Customers who read this summary also read

What Americans Agree on When It Comes to Health
This Could Be Why You’re Depressed and Anxious
How a Long-Forgotten Virus Could Help Us Solve the Antibiotics Crisis
How Humans and AI Can Work Together to Create Better Businesses
Leadership Lessons from the Trenches of Disruption
Why Are Drug Prices So High? Investigating the Outdated US Patent System

Related Channels